Advertisement

Pfizer, Moderna to file FDA COVID-19 vaccine emergency usage as soon as Friday

Before you read:

Bias
Ratings

AllSides
LEAN RIGHT
Media Bias/Fact Check
RIGHT BIAS
5
0

"Hope and help are on the way" to combat the coronavirus pandemic, according to Health and Human Services Secretary Alex Azar, who said Thursday that Pfizer and its partner BioNTech "intend to file for emergency use authorization at the FDA" for its COVID-19 vaccine on Friday.

Continue Reading Below

Pfizer and BioNTech are currently in Phase 3 trials on the vaccine as is fellow pharmaceutical giant, Moderna.

"Two vaccines, each with 95% efficacy, rivaling the 98% efficacy of our measles vaccine. Produced in some of the largest vaccine clinical trials ever conducted in history. Over 40,000 patients in each of these clinical trials demonstrating good safety profiles," Azar said during the White House's Coronavirus task force briefing Thursday.

TickerSecurityLastChangeChange %PFEPFIZER INC.36.19-0.13-0.36%TD Ameritrade Stock Table

The secretary emphasized the importance of the speed with which the vaccines were created — "10 months!"

As for when Moderna will follow Pfizer in the application process, Azar said, "We would expect to see Moderna filing soon."

PFIZER'S COVID-19 VACCINE: WHAT TO KNOW

Azar will join 'Mornings With Maria" on Friday in the 8 AM ET hour.

TickerSecurityLastChangeChange %MRNAMODERNA INC.92.77+3.88+4.36%TD Ameritrade Stock Table

MODERNA'S COVID-19 VACCINE: WHAT TO KNOW

Earlier this week, Moderna CEO Stephane Bancel said his company's coronavirus vaccine has demonstrated a "gamechanger" safety record in ongoing studies, along with 94.5% effectiveness in preventing COVID-19.

Moderna CEO Stephane Bancel joins ‘Mornings with Maria’ to discuss vaccine breakthrough.Video

"People who did got our vaccine did not get any severe disease, which is, of course, a gamechanger," Bancel told "Mornings with Maria" Monday. "We’re very excited to announce this morning that the vaccine at this first interim analysis of phase three, the real test … has shown 94.5% efficacy."

Earlier this week, Azar said that the US could distribute 40 million doses of the Pfizer and Moderna vaccines by the end of the year.

CLICK HERE TO READ MORE ON FOX BUSINESS

Source Link:
https://www.foxbusiness.com/markets/pfizer-covid-november-20-2020

[]

Comments

comments

Advertisement

 

"Hope and help are on the way" to combat the coronavirus pandemic, according to Health and Human Services Secretary Alex Azar, who said Thursday that Pfizer and its partner BioNTech "intend to file for emergency use authorization at the FDA" for its COVID-19 vaccine on Friday.

Continue Reading Below

Pfizer and BioNTech are currently in Phase 3 trials on the vaccine as is fellow pharmaceutical giant, Moderna.

"Two vaccines, each with 95% efficacy, rivaling the 98% efficacy of our measles vaccine. Produced in some of the largest vaccine clinical trials ever conducted in history. Over 40,000 patients in each of these clinical trials demonstrating good safety profiles," Azar said during the White House's Coronavirus task force briefing Thursday.

TickerSecurityLastChangeChange %PFEPFIZER INC.36.19-0.13-0.36%TD Ameritrade Stock Table

The secretary emphasized the importance of the speed with which the vaccines were created — "10 months!"

As for when Moderna will follow Pfizer in the application process, Azar said, "We would expect to see Moderna filing soon."

PFIZER'S COVID-19 VACCINE: WHAT TO KNOW

Azar will join 'Mornings With Maria" on Friday in the 8 AM ET hour.

TickerSecurityLastChangeChange %MRNAMODERNA INC.92.77+3.88+4.36%TD Ameritrade Stock Table

MODERNA'S COVID-19 VACCINE: WHAT TO KNOW

Earlier this week, Moderna CEO Stephane Bancel said his company's coronavirus vaccine has demonstrated a "gamechanger" safety record in ongoing studies, along with 94.5% effectiveness in preventing COVID-19.

Moderna CEO Stephane Bancel joins ‘Mornings with Maria’ to discuss vaccine breakthrough.Video

"People who did got our vaccine did not get any severe disease, which is, of course, a gamechanger," Bancel told "Mornings with Maria" Monday. "We’re very excited to announce this morning that the vaccine at this first interim analysis of phase three, the real test … has shown 94.5% efficacy."

Earlier this week, Azar said that the US could distribute 40 million doses of the Pfizer and Moderna vaccines by the end of the year.

CLICK HERE TO READ MORE ON FOX BUSINESS

Source Link:
https://www.foxbusiness.com/markets/pfizer-covid-november-20-2020

[]

Comments

comments

Advertisement

 

Liberal
Conservative

Headlines

TOPICS & ARTICLES

What are different news outlets reporting on?

SENTIMENT ANALYSIS

What emotions are being provoked?

FACT CHECKING

How true are recent statements and reporting?

Advertisement